Citations to this article

Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. New model to study bone resorption in vivo.
U Trechsel, … , A Stutzer, H Fleisch
U Trechsel, … , A Stutzer, H Fleisch
Published December 1, 1987
Citation Information: J Clin Invest. 1987;80(6):1679-1686. https://doi.org/10.1172/JCI113257.
View: Text | PDF
Research Article

Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. New model to study bone resorption in vivo.

Abstract

A model of stimulated bone resorption was developed using a synthetic retinoid in thyroparathyroidectomized rats. The retinoid induced an increase in bone resorption and in the number of vertebral subperiosteal osteoclasts. The resulting increase in plasma Ca could be used as an easily measured index of bone resorption. Three bisphosphonates produced a dose-related prevention and reversal of retinoid-induced hypercalcemia. Their potencies were similar to those previously obtained by histomorphometry. Irradiation (600 rad) of the rats prevented hypercalcemia but failed to reverse it, showing that proliferation of osteoclast precursor cells was important in inducing, but not in maintaining, bone resorption. Calcitonin produced similar effects on calcemia and prevented the increase in osteoclast number but failed to reverse the increase, suggesting that it inhibited precursor proliferation. This model represents a new tool to study mechanisms of bone resorption and the action of inhibitors in vivo.

Authors

U Trechsel, A Stutzer, H Fleisch

×

Total citations by year

Year: 2024 2022 2021 2019 2018 2016 2015 2014 2013 2011 2010 2008 2007 2006 2005 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1989 1988 Total
Citations: 1 1 1 1 2 1 3 1 1 4 1 2 3 1 2 4 2 5 2 3 1 2 4 3 2 3 2 2 60
Citation information

Citations to this article (60)

Title and authors Publication Year
Vitamin A – discovery, metabolism, receptor signaling and effects on bone mass and fracture susceptibility
Lerner UH 		Frontiers in Endocrinology 2024
Effects of Vitamin A (Retinol) Release from Calcium Phosphate Matrices and Porous 3D Printed Scaffolds on Bone Cell Proliferation and Maturation.
Vu AA, Kushram P, Bose S 		2022
Hypercalcemia is a frequent side effect of 13‐ cis ‐retinoic acid treatment in patients with high‐risk neuroblastoma
M Hoemberg, R Schwenzfeur, F Berthold, T Simon, B Hero 		Pediatric Blood & Cancer 2021
Vitamin A decreases the anabolic bone response to mechanical loading by suppressing bone formation
V Lionikaite, P Henning, C Drevinge, FA Shah, A Palmquist, P Wikström, SH Windahl, UH Lerner 		The FASEB Journal 2019
Clinically relevant doses of vitamin A decrease cortical bone mass in mice
V Lionikaite, KL Gustafsson, A Westerlund, SH Windahl, A Koskela, J Tuukkanen, H Johansson, C Ohlsson, HH Conaway, P Henning, UH Lerner 		Journal of Endocrinology 2018
Effects of retinoids on physiologic and inflammatory osteoclastogenesis in vitro
V Lionikaite, A Westerlund, HH Conaway, P Henning, UH Lerner 		Journal of leukocyte biology 2018
Maternal serum retinol and  -carotene concentrations and neonatal bone mineralization: results from the Southampton Womens Survey cohort
MN Ha ndel, RJ Moon, P Titcombe, B Abrahamsen, BL Heitmann, PC Calder, EM Dennison, SM Robinson, KM Godfrey, HM Inskip, C Cooper, NC Harvey 		The American journal of clinical nutrition 2016
Retinoid Receptors in Bone and Their Role in Bone Remodeling
P Henning, HH Conaway, UH Lerner 		Frontiers in Endocrinology 2015
Experimental models for guided bone regeneration in healthy and medically compromised conditions
N Donos, X Dereka, N Mardas 		Periodontology 2000 2015
Immediate effects of retinoic acid on gene expression in primary murine osteoblasts
TA Yorgan, T Heckt, C Rendenbach, C Helmis, S Seitz, T Streichert, M Amling, T Schinke 		Journal of Bone and Mineral Metabolism 2015
Oral Administration of Soluble Guanylate Cyclase Agonists to Rats Results in Osteoclastic Bone Resorption and Remodeling with New Bone Formation in the Appendicular and Axial Skeleton
BL Homer, D Morton, CM Bagi, JA Warneke, CJ Andresen, LO Whiteley, DL Morris, MA Tones 		Toxicologic pathology 2014
Vitamin A Metabolism, Action, and Role in Skeletal Homeostasis
HH Conaway, P Henning, UH Lerner 		Endocrine reviews 2013
Bisphosphonates: The first 40years
RG Russell 		Bone 2011
The relationship between the chemistry and biological activity of the bisphosphonates
FH Ebetino, AM Hogan, S Sun, MK Tsoumpra, X Duan, JT Triffitt, AA Kwaasi, JE Dunford, BL Barnett, U Oppermann, MW Lundy, A Boyde, BA Kashemirov, CE McKenna, RG Russell 		Bone 2011
High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats
T Lind, PM Lind, A Jacobson, L Hu, A Sundqvist, J Risteli, A Yebra-Rodriguez, A Rodriguez-Navarro, G Andersson, H Melhus 		Bone 2011
Vitamins and bone health: beyond calcium and vitamin D : Nutrition Reviews©, Vol. ••, No. ••
H Ahmadieh, A Arabi 		Nutrition Reviews 2011
Hypercalcemia due to the Administration of All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Report of Two Cases
T Yamamoto, H Tashiro, T Sugao, Y Oka, R Shirasaki, K Kojima, N Akiyama, K Kawasugi, N Shirafuji, T Teramoto 		Nihon Naika Gakkai Zasshi 2010
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
RG Russell, NB Watts, FH Ebetino, MJ Rogers 		Osteoporosis International 2008
Principles of Bone Biology
CJ Rosen, T Niu 		Principles of Bone Biology 2008
Biochemical markers in preclinical models of osteoporosis
MG Sørensen, K Henriksen, S Schaller, MA Karsdal 		Biomarkers 2007
FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats
K Niikura, S Nakajima, M Takano, H Yamazaki 		Bone 2007
Einführung in die Bisphosphonate: Geschichte und Wirkungsmechanismen
H Fleisch 		Der Orthopäde 2007
Bisphosphonates: From Bench to Bedside
RG Russell 		Annals of the New York Academy of Sciences 2006
A NOVEL INHIBITOR OF VACUOLAR ATPase, FR202126, PREVENTS ALVEOLAR BONE DESTRUCTION IN EXPERIMENTAL PERIODONTITIS IN RATS
K NIIKURA, N TAKESHITA, N CHIDA 		The Journal of Toxicological Sciences 2005
A Vacuolar ATPase Inhibitor, FR167356, Prevents Bone Resorption in Ovariectomized Rats With High Potency and Specificity: Potential for Clinical Application
K Niikura, N Takeshita, M Takano 		Journal of Bone and Mineral Research 2005
Die Erfolgsstory einer jungen Wirkstoffklasse: Vom Wasserenthärter zum Pharmakon
HA Fleisch 		Pharmazie in unserer Zeit 2001
Hypercalcemia due to all-trans retinoic acid therapy for acute promyelocytic leukemia: A case report of effective treatment with bisphosphonate
O Sakamoto, M Yoshinari, T Rikiishi, I Fujiwara, M Imaizumi, S Tsuchiya, K Iinuma 		Pediatrics International 2001
α-AMINO ACID DERIVED BISPHOSPHONATES. SYNTHESIS AND ANTI-RESORFTIVE ACTIVITY
DM Mizrahi, T Waner, Y Segall 		Phosphorus Sulfur and Silicon and the Related Elements 2001
Bisphosphonattherapie von Knochenerkrankungen
AA Kurth, L Hovy, T Hennigs 		2001
A selective inhibitor of the osteoclast V-H+-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats
Luciano Visentin, Robert A. Dodds, Maurizio Valente, Paola Misiano, Jeremy N. Bradbeer, Sergio Oneta, Xiaoguang Liang, Maxine Gowen, Carlo Farina 		Journal of Clinical Investigation 2000
Bisphosphonates in Bone Disease
H Fleisch 		Bisphosphonates in Bone Disease 2000
Tiludronate. A new treatment for an old ailment: Paget’s disease of bone
A Morales-Piga 		Expert Opinion on Pharmacotherapy 1999
Trabecular bone turnover, bone marrow cell development, and gene expression of bone matrix proteins after low calcium feeding in rats
H Seto, K Aoki, S Kasugai, K Ohya 		Bone 1999
Selective inhibitors of vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity
C Farina, S Gagliardi 		Expert Opinion on Therapeutic Patents 1999
The pharmacology of bisphosphonates and new insights into their mechanisms of action
RG Russell, MJ Rogers, JC Frith, SP Luckman, FP Coxon, HL Benford, PI Croucher, C Shipman, HA Fleisch 		Journal of Bone and Mineral Research 1999
The Bisphosphonate Odyssey. A Journey from Chemistry to the Clinic
R Graham, G Russell 		Phosphorus Sulfur and Silicon and the Related Elements 1999
Advances in Organ Biology
AJ Liedtke 		Advances in Organ Biology 1998
Bisphosphonates: Mechanisms of Action
H Fleisch 		Endocrine reviews 1998
Osteoporosis
DL Glaser, FS Kaplan 		Spine 1997
Effects of vitamin K2 and calcitonin on bone resorption model induced by vitamin A in thyroparathyroidectomized rats
S Kato, K Sato, T Sato, M Gen, N Miyakoshi 		Journal of Bone and Mineral Metabolism 1997
Effects of an inhibitor of cathepsin L on bone resorption in thyroparathyroidectomized and ovariectomized rats
AJ Millest, SA Breen, BE Loveday, PN Clarkson, CA Simpson, JC Waterton, D Johnstone 		Bone 1997
Effect of bisphosphonates on the increase in bone resorption induced by a low calcium diet
VN Antic, H Fleisch, RC Mühlbauer 		Calcified Tissue International 1996
Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models
Y Azuma, H Sato, Y Oue, K Okabe, T Ohta, M Tsuchimoto, M Kiyoki 		Bone 1995
Tiludronate: Bone pharmacology and safety
JP Bonjour, P Ammann, A Barbier, J Caverzasio, R Rizzoli 		Bone 1995
Retinoic acid suppresses parathyroid hormone (PTH) secretion and PreproPTH mRNA levels in bovine parathyroid cell culture
PN MacDonald, C Ritter, AJ Brown, E Slatopolsky 		Journal of Clinical Investigation 1994
Molecular to pharmacologic control of osteoblast proliferation and differentiation
SR Siddhanti, LD Quarles 		Journal of Cellular Biochemistry 1994
Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocyte leukaemia: case report
J Suzumiya, F Asahara, H Katakami, N Kimura, S Hisano, M Okumura, R Ohno 		European Journal of Haematology 1994
Metastatic Bone Disease
IJ Diel, M Kaufmann, G Bastert 		1994
New bisphosphonates in osteoporosis
H Fleisch 		Osteoporosis International 1993
Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density
P Ammann, R Rizzoli, J Caverzasio, T Shigematsu, D Slosman, JP Bonjour 		Journal of Bone and Mineral Research 1993
Physiology and Pharmacology of Bone
GR Mundy, TJ Martin 		1993
Inhibition of bone resorption by the bisphosphonate BM 21.0955 is not associated with an alteration of the renal handling of calcium in rats infused with parathyroid hormone-related protein
R Rizzoli, J Caverzasio, F Bauss, JP Bonjour 		Bone 1992
Hypercalcaemia due to all-trans retinoic acid
H Akiyama, N Nakamura, S Nagasaka, H Sakamaki, Y Onozawa 		The Lancet 1992
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption
RC Mühlbauer, F Bauss, R Schenk, M Janner, E Bosies, K Strein, H Fleisch 		Journal of Bone and Mineral Research 1991
Sodium EDTA enhances intestinal absorption of two bisphosphonates
M Janner, RC Mühlbauer, H Fleisch 		Calcified Tissue International 1991
Bisphosphonates: Pharmacology and Use in the Treatment of Tumour-Induced Hypercalcaemic and Metastatic Bone Disease
H Fleisch 		Drugs 1991
Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats
R Rizzoli, J Caverzasio, MC Chapuy, TJ Martin, JP Bonjour 		Journal of Bone and Mineral Research 1989
Nephrologie
HJ Gurland, KM Koch, W Schoeppe, P Scigalla 		Néphrologie 1989
Bisphosphonates inhibit 1,25-dihydroxyvitamin D3-induced increase of osteocalcin in plasma of ratsin vivo and in culture medium of rat calvariain vitro
SA Stronski, L Bettschen-Camin, A Wetterwald, R Felix, U Trechsel, H Fleisch 		Calcified Tissue International 1988
Short- and long-term effects of a single dose of bisphosphonates on retinoid-induced bone resorption in thyroparathyroidectomized rats
A Stutzer, H Fleisch, U Trechsel 		Calcified Tissue International 1988

Advertisement